4//SEC Filing
CTI BIOPHARMA CORP 4
Accession 0000891293-16-000154
CIK 0000891293operating
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 6:47 PM ET
Size
9.6 KB
Accession
0000891293-16-000154
Insider Transaction Report
Form 4
NUDELMAN PHILLIP M PHD
Director
Transactions
- Exercise/Conversion
Common Stock
2016-04-29+79,618→ 334,311 total - Exercise/Conversion
Restricted Stock Unit
2016-04-29−79,618→ 0 total→ Common Stock (79,618 underlying) - Award
Restricted Stock Unit
2016-04-29+396,983→ 396,983 total→ Common Stock (396,983 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the right to receive, at settlement, one share of CTIC common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
- [F2]This restricted stock unit was granted on September 23, 2015 and vested on April 29, 2016.
- [F3]Each restricted stock unit represents the right to receive, at settlement, one share of CTIC common stock.
- [F4]This restricted stock unit was granted on April 29, 2016 and scheduled to vest twelve months after grant date or, if earlier, the first annual meeting of CTIC's shareholders in 2017 at which one or more members of the CTIC Board of Directors are to be elected.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000891293
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 6:47 PM ET
- Size
- 9.6 KB